medical guideline
首页
中医/中西医结合指南
肿瘤学指南
泌尿外科指南
关于我们
郑重声明
联系我们
首页
肿瘤学指南
检索结果
人体系统
运动
骨肿瘤
软组织肿瘤
骨与软组织肿瘤
硬纤维瘤
骶尾部畸胎瘤
神经
中枢神经系统肿瘤
嗜铬细胞瘤和副神经节瘤
副神经节瘤
胶质细胞瘤
前庭神经鞘瘤
星形胶质细胞瘤和少突胶质细胞瘤
弥漫性胶质瘤
神经纤维瘤
神经细胞瘤
神经内分泌肿瘤
内分泌
甲状腺肿瘤
垂体肿瘤
肾上腺肿瘤
甲状旁腺肿瘤
胸腺肿瘤
神经内分泌肿瘤
循环
心脏肿瘤
淋巴瘤
骨髓瘤
白血病
血液肿瘤
血管瘤
呼吸
肺癌
鼻咽癌
喉部肿瘤
下咽癌
鼻腔和副鼻窦癌
呼吸道肿瘤
鼻颅咽管瘤
淋巴管肌瘤
消化
胰腺肿瘤
口腔癌
肛门癌
口咽癌
胆囊癌
胆管肿瘤
直肠癌
结肠癌
胃癌
小肠癌
肝癌
大肠肿瘤
唾液腺癌
阑尾肿瘤
食管肿瘤
肝肿瘤
壶腹肿瘤
肝胆癌
结直肠肿瘤
食管胃肿瘤
胃肠道肿瘤
消化道肿瘤
泌尿
膀胱肿瘤
肾癌
脐尿管癌
尿路上皮癌
肾血管平滑肌脂肪瘤
泌尿生殖肿瘤
生殖
女性
子宫肿瘤
卵巢肿瘤
乳腺肿瘤
阴道肿瘤
输卵管癌
外阴癌
妊娠滋养细胞肿瘤
妇科肿瘤
男性
前列腺肿瘤
性索间质瘤
睾丸肿瘤
阴茎癌
男性乳腺肿瘤
泌尿生殖肿瘤
其他
症状管理
治疗方案
诊断/检测/评估方法
预防和筛查
COVID-19大流行癌症患者相关指导建议
皮肤肿瘤
黑色素瘤
头颈部肿瘤
康复营养
生育能力
体力活动
心理健康
腹膜肿瘤
实体瘤
胸部肿瘤
长期监测
Cowden综合征
转诊
遗传性癌症综合征
癌症患者其他类问题管理
寡转移性疾病
基因测序
易感基因变异的分类
外科肿瘤
罕见癌症
不明原因癌症
纤维瘤
腹部肿瘤
老年肿瘤
儿童/青少年肿瘤
人类微生物组与癌变
检索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
按发表年份
共搜索到
9条
与
Oligometastatic
有关的结果
Consensus Statements on PSMA PET/CT Response Assessment Criteria in Prostate Cancer
2021年 发布于
European Journal of Nuclear Medicine and Molecular Imaging
48卷 第2期
所属人体系统:
生殖
|
前列腺肿瘤
无
Monitoring
Oligometastatic
Prostate Cancer
PERCIST
PET/CT
PSMA Ligand
Polymetastatic Prostate Cancer
Prostate Cancer
Prostate-specific Membrane Antigen (PSMA)
RECIST
指南简介
原文链接
Defining Oligometastatic Disease from a Radiation Oncology Perspective: an ESTRO-ASTRO Consensus Document
2020年 发布于
Radiother Oncol
148卷 第期
所属人体系统:
其他
|
治疗方案
European Society for Radiotherapy AndOncology
American Society for Radiation Oncology
ASTRO
Consensus Document
Curative Intent
ESTRO
Metastasis-directed Radiotherapy
Oligometastatic
.
指南简介
原文链接
Characterisation and Classification of Oligometastatic Disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer Consensus Recommendation
2020年 发布于
Lancet Oncol
21卷 第1期
所属人体系统:
其他
|
寡转移性疾病
European Society for Radiotherapy and Oncology
European Organisation for Research and Treatment of Cancer
Oligometastatic
Disease
Characterisation
Classification
Consensus
指南简介
原文链接
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
2020年 发布于
Eur Urol
77卷 第4期
所属人体系统:
生殖
|
前列腺肿瘤
Advanced Prostate Cancer Consensus Conference 2019
Advanced Prostate Cancer
Castration-naïve Prostate Cancer
Castration-resistant Prostate Cancer
Genetics
High-risk Localised Prostate Cancer
Hormone-sensitive Prostate Cancer
Imaging
Oligometastatic
Prostate Cancer
Overall Survival
Progression-free Survival
Prostate Cancer Treatment
Tumour Genomic Profiling
指南简介
原文链接
Definition of Synchronous Oligometastatic Non–Small Cell Lung Cancer—A Consensus Report
2019年 发布于
J Thorac Oncol
14卷 第12期
所属人体系统:
呼吸
|
肺癌
无
Consensus Definition
Non–small Cell Lung Cancer
Oligometastatic
Disease
Staging
指南简介
原文链接
Consensus Statements on Ablative Radiotherapy for Oligometastatic Prostate Cancer: a Position Paper of Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2019年 发布于
Crit Rev Oncol Hematol
138卷 第_期
所属人体系统:
生殖
|
前列腺肿瘤
Italian Association of Radiotherapy and Clinical Oncology
Ablative Radiotherapy
Oligometastatic
Prostate Cancer
SABR
SBRT
Stereotactic Radiotherapy
指南简介
原文链接
German S3 Guideline for Renal Cell Carcinoma : Presentation and Discussion of Essential Aspects for the Radiation Oncologist
2018年 发布于
Strahlenther Onkol
194卷 第1期
所属人体系统:
泌尿
|
肾癌
无
Purpose: We Aim to Introduce and Discuss the Statements and Recommendations of the German S3 Guideline on Renal Cell Cancer for Daily Practice of Radiation Oncologists
Methods: This Report Comprises Indication
Treatment Decision
Dose Prescription and Current Literature Including Treatment of
Oligometastatic
Disease
Results: According to Different Stages of the Disease and the Structure of the Guideline We Focus on Five Treatment Situations and Recommendations for Decision Making: (1) Neo-/adjuvant Treatment Before Or after Nephrectomy: No Indication for Radiotherapy (2) Small Renal Mass: Stereotactic Ablative Radiotherapy Is Currently Seen as Experimental Option due to Small Patient Numbers Reported in the Literature However
Local Tumor Control Achieved by SBRT Appears Favourable with >90% at 2 Years (3) Oligometastasis: Radiation Treatment with Higher Local Doses Or Stereotactic Treatment Is Possible after Interdisciplinary Discussion Indications for Palliative (4) and Symptomatic Treatment (5) Are Not Different Compared to Other Tumor Entities
Conclusion: Currently
There Is No Evidence-based Indication for Radiation Treatment in the Primary Setting (adjuvant/neoadjuvant Or Definitive) of Renal Cell Cancer in the Future Stereotactic Radiotherapy Should Have a Stronger Role in the Treatment of Medically Inoperable Patients with Primary Renal Cell Cancer and Especially in the Setting of Oligometastasis
指南简介
原文链接
Use of Modern Imaging Methods to Facilitate Trials of Metastasis-directed Therapy for Oligometastatic Disease in Prostate Cancer: a Consensus Recommendation from the EORTC Imaging Group
2018年 发布于
Lancet Oncol
19卷 第10期
所属人体系统:
生殖
|
前列腺肿瘤
EORTC Imaging Group
Oligometastatic
Disease
prostate Cancer
指南简介
原文链接
Management of Patients with Advanced Prostate Cancer: the Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017 [Figure Presented]
2018年 发布于
Eur Urol
73卷 第2期
所属人体系统:
生殖
|
前列腺肿瘤
The Advanced Prostate Cancer Consensus Conference (APCCC) 2017
Advanced and High-risk Localized Prostate Cancer
Castration-naive and Castration-resistant Prostate Cancer
Consensus
Oligometastatic
Prostate Cancer
Therapeutics
指南简介
原文链接